Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2007 061 710.3 |
| 96 | EP file number | EAKZ | 21 19 4622.3 |
| 97 | EP publication number | EPN | 3984528 |
| 54 | Designation/title | TI | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND NILOTINIB |
| 51 | IPC main class | ICM
(ICMV) | A61K 9/16 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/506 (2006.01), A61P 35/02 (2006.01), A61P 35/00 (2006.01), A61P 43/00 (2006.01) |
| 22 | DE application date | DAT | Sep 25, 2007 |
| 96 | EP application date | EAT | Sep 25, 2007 |
| 43 | Date of first publication | OT | Apr 20, 2022 |
| Date of publication of grant | PET | Jul 5, 2023 |
| 71/73 | Applicant/owner | INH | Novartis AG, Basel, CH |
| 72 | Inventor | IN | Bruneau, Nathalie, 06700 Saint-Laurent du Var, FR |
| Address for service | | NOVARTIS AG, 4056 Basel, CH |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| EP
06121371
Sep 27, 2006
|
| Due date | FT
FG | Sep 30, 2025
Annual fee for the 19th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003984528A1
Searchable text:
EP000003984528A1
Original document:
EP000003984528B1
Searchable text:
EP000003984528B1 |
| 43 | Date of first publication | EVT | Apr 20, 2022 |
| Date of the first transfer into DPMAregister | EREGT | Apr 20, 2022 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 27, 2024
(Show all update days)(Hide all update days)- Aug 27, 2024
- Jun 20, 2024; May 23, 2024; Sep 1, 2023; Jul 20, 2023; Jun 15, 2023
- Historical data not available for this/these date(s)
- Apr 20, 2022
- Date of the first transfer into DPMAregister
|
